What are they?
During the first few weeks of pregnancy a baby’s brain, spinal cord and its’ coverings develop. The cells that grow to form these structures do so by first forming into a tube - the neural tube. If the tube does not close fully, the opening that is left is called a neural tube defect (NTD).
Normally, the spinal cord and brain are surrounded and cushioned by cerebrospinal fluid (CSF) and are protected by outer layers of tissue called the meninges. The brain is also protected by the skull, and the spinal cord is protected by the backbone (spine), formed by bones called vertebrae. When someone has an NTD, there are one or more gaps in the brain or spinal cord’s protection. This can affect the brain’s development and can leave the spinal cord vulnerable to damage. Because the spinal cord contains the nerves that control body movement, any damage that occurs can paralyse or weaken associated muscles and organs.
The reason why the neural tube may develop incorrectly is not known for sure, but probably involves both genetic and environmental factors.
Spina bifida, is the most common type of NTD. It occurs when the neural tube does not close completely somewhere along the backbone/spine. Symptoms vary from person to person and can change over time. They tend to occur below the defect and may range from few or none, to partial or total lower body weakness, loss of feeling, or paralysis. Complications will also vary. Cases of spina bifida are generally classified as either “closed” where the skin covers the defect or as “open” where the skin is not intact. Variants include:
Closed Neural Tube Defects
Spina Bifida Occulta
Spina bifida occulta is often called hidden spina bifida. A small gap may exist in one or more of the bones of the spine, but the spinal cord and tissues are normal. Many people with this condition do not have any symptoms and may never know that it exists unless it is identified during testing that is done for another reason.
Closed neural tube defects are frequently grouped with spina bifida occulta. They consist of a wide variety of spinal defects with malformed bone, tissue, and/or fat deposits at the location of the defect. Often there is a visible sign on the outside of the baby’s skin. This may be a tuft of hair, a dimple, a birthmark, lump, or skin opening. Many patients with this condition will have few symptoms, but some may have nerve damage that affects normal bowel or bladder function and/or can cause lower body weakness and pain.
Open Neural Tube Defects
Meningocele
With this type of spina bifida, cerebrospinal fluid (fluid from around the brain) and meninges (membranes covering brain) have ballooned out of the spinal opening to form a bulge or sac, but the spinal cord is usually in its normal location. This bulge may or may not be covered with a layer of skin. This bulge will be noticeable on the back of the baby. Symptoms are variable.
Myelomeningocele
This is the most severe type of spina bifida. It develops when the cerebrospinal fluid, meninges, and the spinal cord protrude through the opening in the spine. It leaves the spinal cord vulnerable to damage and can cause paralysis in those parts of the body below the opening. Affected patients frequently have bowel and bladder problems. Some will require assistance to walk and others will require a wheel chair. Newborns with this condition are at an increased risk of developing meningitis.
Up to 80 to 90 percent of people with spina bifida will develop hydrocephalus. This occurs when the flow of cerebrospinal fluid is blocked and builds up in the brain. The child’s head becomes larger and there is increased pressure on the brain. Left untreated, this condition can cause mental retardation and learning disabilities and can in some cases be fatal. Hydrocephalus is usually treated by putting in a tube called a shunt that allows excess cerebrospinal fluid to drain into the abdomen (tummy).
Anencephaly is the term used for an NTD that affects the head. The result is the lack of development of a large portion of the brain and skull. Some babies affected are stillborn. Those that are born alive are usually unconscious, unable to feel pain, deaf, and blind. Most of those affected die within a few hours or days.
There are a variety of other, rarer forms of NTDs. All are associated with a lack of proper neural tube formation.
Laboratory Tests
Laboratory tests used to screen for the presence of NTD during pregnancy may include measurement of alpha-fetoprotein (AFP) in the mother's blood. This is a protein made by the developing baby that crosses the placenta, into the mother's blood stream. Levels rise during the first half of pregnancy, but will be particularly high if an open NTD is present as higher amounts cross to the mother. The concentration of AFP in the maternal blood may also be higher than expected in a twin pregnancy, or if the pregnancy is at a later stage than estimated.
Non-Laboratory Tests
Tests include:
- Foetal ultrasound – to help diagnose NTDs prior to birth.
- X-ray, MRI (magnetic resonance imaging), and/or CT scan (computed tomography) – of spine and vertebrae after birth to look for defects and deformities.
- X-ray or CT scans of the head to detect excess fluid when hydrocephalus is suspected.
Regular clinical examinations – to detect and address complications as they arise.
Tests offered during pregnancy vary from region to region, please discuss available tests with your doctor or midwife.
The goals of treatment are to prevent as many cases of neural tube defect as possible, and for those affected, to minimise symptoms and complications. Treatments for NTD must be tailored to the individual, and may require surgery, sometimes within a few days of birth.
For prevention of NTD, adequate folate/folic acid intake by mothers is essential. Folic acid can be found in dark green vegetables and some fruit and beans as well as in other foods, but a supplement to diet is recommended. Folic acid supplementation of 0.4 mg a day reduces the incidence of NTDs, but the supplementation must be started before conception and continued for the first 12 weeks of pregnancy. That means all women of child bearing age should consider taking folate supplements. Women who have spina bifida, or who already have a child with spina bifida, or who are otherwise considered at an increased risk of having a baby with an NTD should take 5 mg of folic acid a dayfor several months before becoming pregnant. This higher dose is not recommended, however, for the general population.
Tests offered during pregnancy vary from region to region.